Hong Kong’s pharmaceutical licensing regime covers medicines sold, supplied, distributed or displayed in Hong Kong, including proprietary Chinese medicines. Cross-border sales involve importing products into Hong Kong; the medicines must hold valid Hong Kong pharmaceutical licences and comply with local labelling and safety standards. Sales into the Hong Kong market through online platforms are also regarded as supply in Hong Kong and must be compliant. Rengangyongsheng (Hong Kong) Limited assists clients throughout the process with import permits, pharmaceutical licence applications and subsequent compliance oversight, to support the lawful circulation of proprietary Chinese medicines across borders.
HONG KONG DRUG LICENSING
What exactly is the scope of Hong Kong pharmaceutical licences when proprietary Chinese medicines are sold cross-border?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions